Sanofi (SNY) Non-Current Assets (2009 - 2026)

Sanofi (SNY) posted Non-Current Assets of $114.6 billion for Q1 2026, up 2.68% sequentially from $111.6 billion in Q4 2025, and up 23.95% YoY from $92.4 billion in Q1 2025.

Sanofi (SNY) Non-Current Assets (2009 - 2026) Analysis & Trends

Sanofi (SNY) has 18 years of Non-Current Assets data on file, last reported at $114.6 billion in Q1 2026.

  • Quarterly Non-Current Assets rose 23.95% year-over-year to $114.6 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $114.6 billion (up 23.95% YoY) and the FY2025 annual result came in at $111.6 billion, up 15.75% from the prior year.
  • Non-Current Assets advanced to $114.6 billion in Q1 2026 per SNY's latest filing, from $111.6 billion in the prior quarter.
  • The five-year high for Non-Current Assets was $114.6 billion in Q1 2026, with the low at $92.4 billion in Q1 2025.
  • Average Non-Current Assets over 5 years is $103.1 billion, with a median of $103.1 billion recorded in 2023.
  • Year-over-year, Non-Current Assets slipped 7.81% in 2022 and climbed 23.95% in 2026.
  • Sanofi's Non-Current Assets stood at $94.5 billion in 2022, then advanced by 9.08% to $103.1 billion in 2023, then fell by 6.47% to $96.4 billion in 2024, then grew by 15.75% to $111.6 billion in 2025, then advanced by 2.68% to $114.6 billion in 2026.
  • Business Quant data shows SNY's Non-Current Assets at $114.6 billion in Q1 2026, $111.6 billion in Q4 2025, and $111.9 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 61.74 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 141.72 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 102.93 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn 84.40 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 125.00 Mn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 61.03 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 37.64 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 165.18 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Sanofi - - 9.49 Bn 114.57 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 114.57 Bn
Dec 31, 2025 111.58 Bn
Sep 30, 2025 111.94 Bn
Jun 30, 2025 99.55 Bn
Mar 31, 2025 92.43 Bn
Dec 31, 2024 96.40 Bn
Jun 30, 2024 107.34 Bn
Dec 31, 2023 103.07 Bn
Jun 30, 2023 103.57 Bn
Dec 31, 2022 94.49 Bn
Jun 30, 2022 99.43 Bn
Dec 31, 2021 102.49 Bn
Jun 30, 2021 99.62 Bn
Dec 31, 2020 96.13 Bn
Jun 30, 2020 89.15 Bn
Dec 31, 2019 667.01 Mn
Jun 30, 2019 95.69 Bn
Dec 31, 2018 99.03 Bn
Jun 30, 2018 104.20 Bn
Mar 31, 2018 100.61 Bn